Stock Events

Stock Events

Lineage Cell Therapeutics (LCTX.TA) Q2 2024 Earnings

9MayConfirmed

Q4 2023

Q2 2024

-14.91

-9.95

-4.99

-0.03

Details

Expected EPS

-14.289699074

Actual EPS

-14.91112

Surprise EPS

-0.62

Surprise Percent

+4.35%

Description

Lineage Cell Therapeutics (LCTX.TA) has reported earnings of -14.91112 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.